With highly experienced diabetes and endocrinology specialists at Columbia and Weill Cornell Medicine, our programs are recognized for excellence in achieving optimal outcomes for challenging metabolic conditions and chronic diseases by providing multidisciplinary care to all patients. Our experts conduct research on developing innovative treatments and compassionately address the physical and emotional toll these prolonged diseases can have on patients and their families.
Diabetes & Endocrinology
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
Featured Updates
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, chair of the Department of Otolaryngology – Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
